Literature DB >> 30880701

A study of influenza 2017-2018 outbreak in Andhra Pradesh, India.

Nagaraja Mudhigeti1, Rishi Gowtham Racherla1, Padmalatha Anjaneyulu Mahalakshmi1, Madhavi Latha Pamireddy1, Umapathi Nallapireddy1, Meenakshi Kante1, Usha Kalawat1.   

Abstract

BACKGROUND AND OBJECTIVES: Influenza virus is a typical human pathogen causing serious respiratory illness resulting in significant mortality throughout the globe. Andhra Pradesh witnessed the first case of influenza A H1N1 in India from Hyderabad (now in Telangana) on May 16, 2009. In the recent past, Andhra Pradesh witnessed exponential increase in the number of confirmed cases of influenza infection. In this study, we present the salient features of the recent outbreak of influenza during 2017-2018 in the state of Andhra Pradesh, first of its kind after the division of the state.
MATERIALS AND METHODS: Clinically, suspected cases of influenza-like illness received in the Virus Research and Diagnostic Laboratory, Department of Microbiology, Sri Venkateswara Institute of Medical Sciences (SVIMS), Tirupati, from January 2017 to May 2018 were included in the study. The samples were tested for influenza A, influenza A (H1N1) pdm09, influenza A (H3N2), influenza B, influenza B/Yamagata and influenza B/Victoria.
RESULTS: A total of 1286 samples were received for testing. The positive samples were influenza A unsubtypable (109), influenza A (H1N1) pdm09 (356), influenza A (H3N2) (38) and influenza B (19; Victoria - 2, Yamagata - 17). There was no significant difference in positivity between genders with 260 (49.81%) females and 262 (50.19%) males being positive.
CONCLUSION: The outbreak started in the late monsoon (January) of 2017 and had two peaks; one in summer months and another in winter months. Influenza B virus was reported from December 2017 to May 2018. Age groups ≤5 years and 6-18 years had higher positivity as compared to other age groups. Regular surveillance programmes are required for assessing the trends of influenza infections due to various subtypes and to plan timely and adequate steps for preventing the spread to larger vulnerable population.

Entities:  

Keywords:  Andhra Pradesh; India; influenza; outbreak

Mesh:

Year:  2018        PMID: 30880701     DOI: 10.4103/ijmm.IJMM_18_272

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   0.985


  1 in total

1.  Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy children (6 months to 17 years of age): a randomized, multicenter, phase III clinical trial.

Authors:  Sumantra Sarkar; Chandrakant Bokade; Kapil Garg; Ravi Kumar; Jayesh Sanmukhani; Ravindra Mittal
Journal:  Hum Vaccin Immunother       Date:  2020-08-26       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.